Stocks · News reference
8-K filing — Roivant Sciences Ltd. (ROIV)
Filed: 2026-09-08 AccNo: 0001140361-26-035859 Size: 190 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Guggenheim Maintains Buy on Roivant Sciences, Raises Price Target to $46
HC Wainwright & Co. Maintains Buy on Roivant Sciences, Raises Price Target to $47
S&P 500, Nasdaq Slip as $98 Brent Reignites Inflation Fears: Stock Market Today
Crude near $98 pushes the 10-year Treasury yield above 4.8% for the first time since 2023, hammering the Dow as traders price a Fed rate hike next week.